Emotion is a part of the investing game and can be hard to master when a favorite company falls on hard times.
Even when their drugs are doing well, companies in this industry don't necessarily yield big rewards for investors.
Look for solid performers that lack a natural buying constituency.
Zeke Ashton rounds out the 10 commandments of value investing.
Searching for value is an easy-to-follow formula.
The art of value investing rests upon a timeless set of core principles.
Sharpen your skills by learning from the heaviest hitters.
The love/hate cycle might be ready to shift again for this pharmaceutical.
The online postal purveyor announces a reverse split and a huge dividend.
Zeke Ashton has advice to shape up your portfolio and help you achieve your financial goals.
Zeke Ashton trusts Utah Medical will find a good use for a well-deserved windfall.
Is there such a thing as "good turnover"?
Successful turnarounds invariably start at the top.
Is an outburst on a Cree conference call a signal to stay out of the stock?
Can a giant drug maker overcome patent expiration and prosper?
The new CEO is the man for the job, but it's a tough, tough job.
As Zeke Ashton explains, buybacks don't always serve shareholders.
Dividends aren't the only ways companies give back to investors.
Great portfolios and winning ball clubs have more in common than you think.
Zeke Ashton praises the energy company's shareholder-centric management team.